Mar 25, 2013
Cambridge Cognition, one of the 10 Companies to Watch in 2013/ 2014 according to our latest market report, just announced its plans to go public in the UK’s AIM market.
Cambridge Cognition in £15M AIM IPO (Business Weekly): “… the move will value the business at around £15 million. It is hoped the shares will be admitted to AIM on April 8…The group develops and commercialises computerised neuropsychological tests for sale worldwide, principally in the UK – its main country of operation – the US and Europe…CCL has two established product streams, CANTABelect (for clinical research and trials) and CANTABeclipse (for academic and other research)…A third product, CANTABmobile, an approved Class II medical device, was launched in the UK in May 2012.”
To Learn More: